Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012

NCT01056263 · clinicaltrials.gov ↗

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: axitinib: observational study

Sponsor

Pfizer